Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma.
about
Endocrine neoplasms in familial syndromes of hyperparathyroidismHypercalcemia of Malignancy: An Update on Pathogenesis and ManagementHypercalcemia of malignancy and new treatment optionsParathyroid cancerPharmacology of the calcium sensing receptorEpigenetic Alterations in Parathyroid CancersPhysiology and pathophysiology of the calcium-sensing receptor in the kidneyClinical Use of Cinacalcet in MEN1 HyperparathyroidismHuman chorionic gonadotropin measurements in parathyroid carcinoma.Challenges and pitfalls in the management of parathyroid carcinoma: 17-year follow-up of a case and review of the literatureParathyroid cancer.LC-MS/MS determination of cinacalcet enantiomers in rat plasma on Chirobiotic V column in polar ionic mode: application to a pharmacokinetic study.Cinacalcet HCl reduces hypercalcemia in primary hyperparathyroidism across a wide spectrum of disease severityCinacalcet reduces serum calcium concentrations in patients with intractable primary hyperparathyroidismParathyroid carcinoma: current understanding and new insights into gene expression and intraoperative parathyroid hormone kineticsNew concepts in calcium-sensing receptor pharmacology and signallingClinical and biochemical outcomes of cinacalcet treatment of familial hypocalciuric hypercalcemia: a case seriesExperience with cinacalcet in primary hyperparathyroidism: results after 1 year of treatment.Cinacalcet as alternative treatment for primary hyperparathyroidism: achievements and prospects.Severe Hyperparathyroidism Versus Parathyroid Carcinoma: A clinical dilemma.Parathyroid carcinoma: increasing incidence and changing presentation.Parathyroid carcinoma: update and guidelines for management.Cinacalcet: will it play a role in reducing cardiovascular events?Nonsurgical management of mild primary hyperparathyroidism - a reasonable option.Endocrine and metabolic emergencies: hypercalcaemia.Cinacalcet hydrochloride for the treatment of hyperparathyroidism.Hypercalcemia in the Intensive Care Unit: A Review of Pathophysiology, Diagnosis, and Modern Therapy.The Use of Calcimimetics for the Treatment of Secondary Hyperparathyroidism: A 10 Year Evidence Review.Update on parathyroid carcinoma.Potential utility of cinacalcet as a treatment for CDC73-related primary hyperparathyroidism: a case report.The use of hemodialysis in refractory hypercalcemia secondary to parathyroid carcinomaCurrent status of parathyroidectomy for secondary hyperparathyroidism in Japan.Cinacalcet is effective in the treatment of hyperparathyroidism secondary to malignant transformation of autotransplanted parathyroid tissue. A case report.Comparison of active vitamin D compounds and a calcimimetic in mineral homeostasis.Investigating the molecular mechanism of positive and negative allosteric modulators in the calcium-sensing receptor dimer.The use of cinacalcet in pregnancy to treat a complex case of parathyroid carcinoma.Cinacalcet normalizes serum calcium in a double-blind randomized, placebo-controlled study in patients with primary hyperparathyroidism with contraindications to surgery.Hypercalcemia of malignancy treated with cinacalcet.Parathyroid Carcinoma in Patients that Have Undergone Surgery for Primary Hyperparathyroidism.Cinacalcet hydrochloride relieves hypercalcemia in Japanese patients with parathyroid cancer and intractable primary hyperparathyroidism.
P2860
Q26747174-C900D397-D667-43DE-9B84-2FDEBA40F7F8Q26771719-29CD1AC9-25C8-4638-A1AB-A48FB431814DQ26775300-A9A9D445-AC39-470E-B046-4DB6B1F9E8B9Q26796612-4B6839DF-5E7D-4941-8373-3B1302F2C65CQ26860064-593B8536-5B03-4980-A70C-2F14E30A38BEQ30398206-D430F74F-B2B7-481E-8B8D-7AFE2FE83E4BQ33727776-AAB7C1C1-15CD-48C2-8B05-7A25A36214FAQ33879558-0788C503-2A8F-4EEB-9F4B-30F9338B89E3Q34269074-84D88927-EB7C-4DCD-BAD9-80D2FC06BA8CQ34398386-48637E18-4F14-4CDE-A5FA-281511160EC1Q34686824-A7A05063-BA9C-4980-9C30-1DBCD01DB2E3Q35166456-E4BAF4A2-32D6-485F-AE9A-8A708AE2A7DFQ35468992-47AA6A9F-E428-4C2F-A8C4-31E47E77290CQ35545384-FF7EC518-2288-494F-8E26-E516574A9538Q35583695-55AE4FBB-A1C9-4CF5-98F5-D66B47618DAEQ35657894-523BABE5-AE74-4270-9A7B-45538737FCA3Q35779795-2B7E76FA-2241-49C6-9ECE-B21C880617B8Q36883330-27DB5F24-6676-460A-B962-C281D1803763Q37858461-39490E6B-D5F5-450B-A6D0-554B24771F8EQ37867495-B7A5673C-2009-4CA0-B13A-4A351FDF71BCQ37980468-63C1A107-D8A0-467D-8EC9-DEF2B2CAA2EBQ37983468-38C386C1-5F90-40DA-8F04-C1105B6A7FE2Q37993874-6EDBC98B-EE20-49AB-A133-C4C2EC2E64B1Q38026863-7847D8EA-377D-4637-8DD7-8A12D2C7CF4CQ38059483-7830B1B2-FD22-4EB9-8CEF-B02976824A75Q38085702-C15BF987-DD75-492F-B1F1-C80A8781ED7FQ38153026-7A3CE846-F579-4076-B7C4-568BE2FAD570Q38370743-C777F16B-D802-41F0-9580-07B5C2D84DBAQ38784218-4D292478-4D4A-417F-8A53-D486884D5588Q38923460-CDCD1480-61D7-4807-87E1-8B95CFE39AF0Q39224516-EE62C5BA-0390-4AA4-96A1-4B1BF089B54CQ40318011-F771B942-9091-40B9-ABE1-8402505C0B06Q41086630-961CE326-FB89-4F0B-B599-464B099F0676Q41575719-B1D48F3A-560D-46BB-B4CF-CDE973B31400Q42150009-E32CBC64-EFFF-481F-8379-D9BC89D43C61Q42914514-77FFC982-97A1-4BBF-9ABA-03256FCC149EQ46369997-A4977958-C99A-4DF5-A6A8-89E1052D7156Q49207905-BAD2AE35-67C5-48A9-AA43-271AA7E5047DQ49216758-CB43A71E-6882-45CF-BCC5-280068FCAE9BQ50223055-769EBF25-2F2F-4831-9E46-F06C9AFCCF13
P2860
Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Cinacalcet hydrochloride reduc ...... perable parathyroid carcinoma.
@ast
Cinacalcet hydrochloride reduc ...... perable parathyroid carcinoma.
@en
Cinacalcet hydrochloride reduc ...... perable parathyroid carcinoma.
@nl
type
label
Cinacalcet hydrochloride reduc ...... perable parathyroid carcinoma.
@ast
Cinacalcet hydrochloride reduc ...... perable parathyroid carcinoma.
@en
Cinacalcet hydrochloride reduc ...... perable parathyroid carcinoma.
@nl
prefLabel
Cinacalcet hydrochloride reduc ...... perable parathyroid carcinoma.
@ast
Cinacalcet hydrochloride reduc ...... perable parathyroid carcinoma.
@en
Cinacalcet hydrochloride reduc ...... perable parathyroid carcinoma.
@nl
P2093
P356
P1476
Cinacalcet hydrochloride reduc ...... perable parathyroid carcinoma.
@en
P2093
D M Shoback
J P Bilezikian
L E Schwanauer
R C Smallridge
S J Silverberg
P304
P356
10.1210/JC.2007-0585
P407
P577
2007-07-31T00:00:00Z